650
Participants
Start Date
July 31, 2011
Primary Completion Date
May 31, 2014
Study Completion Date
September 30, 2014
MVA85A/AERAS-485
Subjects received intradermal injection of MVA85A/AERAS-485 on Study Day 0, followed 6-9 months later by a booster injection of MVA85A/AERAS-485.
Placebo
Subjects received an intradermal injection placebo on Study Day 0, followed 6-9 months later by a booster injection of placebo.
Hopital Aristide Le Dantec, Dakar
University of Cape Town, Cape Town
Lead Sponsor
University of Oxford
OTHER
European and Developing Countries Clinical Trials Partnership (EDCTP)
OTHER_GOV
Aeras
OTHER